Pandemic has greatly slowed pace of cancer research
By
To the ever-growing list of COVID-19 s collateral damage, add one more casualty: cancer research.
A new study indicates that during the first wave of the pandemic last spring, the number of newly launched cancer treatment studies cratered by 60%.
Advertisement In short, the first wave of COVID slowed scientific progress in a health-related area distant from the disease itself, said study author Dr. Elizabeth Lamont, senior medical director of Acorn AI, in Boston.
The finding follows a review of data collected by the Medidata Enterprise Data Store, which accounts for nearly 30% of all cancer research.